Qube Research & Technologies (QRT)
SRNE

Qube Research & Technologies (QRT)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,034,729
Closed -$917K – 3177
2022
Q4 		$917K Buy
1,034,729
+710,440
+219% +$942K ﹤0.01% 1256
2022
Q3 		$509K Buy
324,289
+276,396
+577% +$627K ﹤0.01% 1459
2022
Q2 		$96K Sell
47,893
-251,614
-84% -$435K ﹤0.01% 1961
2022
Q1 		$698K Buy
299,507
+274,669
+1,106% +$857K 0.01% 1366
2021
Q4 		$115K Buy
+24,838
New +$154K ﹤0.01% 2111

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SRNE Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 1,034,729 shares — an estimated $917K sold.

Qube Research & Technologies (QRT) first reported a position in SRNE in Q4 2021 and held it in 5 quarters. The position peaked at $917K in Q4 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Qube Research & Technologies (QRT) reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,034,729 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $917K.
  • Qube Research & Technologies (QRT) first reported a position in Sorrento Therapeutics, Inc. in Q4 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Sorrento Therapeutics, Inc. position peaked at $917K in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.